Skip to main navigation
Skip to search
Skip to main content
Sort by
Immunology and Microbiology
Autophagy
88%
Cancer Cell
61%
Immune Response
58%
Natural Killer Cell
57%
Tumor Cell
53%
Cancer Immunotherapy
36%
Immunotherapy
36%
Immunocompetent Cell
34%
Programmed Death-Ligand 1
29%
Chemokine Receptor
28%
Tumor Immunity
23%
Immunosurveillance
22%
Chemokine
21%
Susceptibility
19%
Agonist
19%
Epithelial Mesenchymal Transition
18%
Cell Function
17%
Immunosuppressive Drug
16%
CCL5
15%
Mouse Model
14%
Regulatory T Cell
14%
Multiple Myeloma
14%
Hypoxia Inducible Factor 1
14%
Cytotoxic T Cell
12%
Stroma
12%
CXCR3
11%
Actin
11%
Myeloma Cell
10%
Myeloid-Derived Suppressor Cell
10%
Immune Checkpoint Blockade
10%
CXCL10
10%
Cell Mediated Cytotoxicity
10%
Upregulation
10%
CD47
9%
Protein Targeting
9%
Stimulator of Interferon Genes
9%
Cell Killing
9%
Macrophage
9%
Effector Cell
8%
T Cell
8%
Immune Escape
8%
Cell Migration
8%
Carcinoma Cell
8%
Tumor Escape
8%
Carbon Cycle
8%
Cytokine
7%
Immune Landscape
7%
Serine
7%
Molecular Interaction
7%
Cytotoxicity
6%
Therapeutic Target
6%
Gene Expression
6%
Extracellular Matrix
6%
Immunosuppression
6%
Programmed Death 1 Ligand 1
6%
Interferon Type I
6%
Mitochondrion
6%
Tumor Hypoxia
5%
In Vitro
5%
CD8
5%
Immune Checkpoint Inhibitor
5%
Cytoskeleton
5%
Cell Activity
5%
Cell Invasion
5%
Target Cell
5%
Exosome
5%
Mediator
5%
CXCR4
5%
Antigen Presentation
5%
Mesenchymal Stem Cell
5%
Cytotoxic T-Cell
5%
Immune Tolerance
5%
Keyphrases
Autophagy
68%
Hypoxia
48%
Natural Killer Cells
48%
Tumor Microenvironment
47%
Antitumor Immune Response
35%
Cancer Immunotherapy
34%
Tumor
30%
Atypical Chemokine Receptor
26%
In Cancer
23%
Microenvironment
22%
Tumor Cells
21%
Cancer Cells
19%
Breast Cancer Cells
19%
Chemokines
18%
Hypoxic Tumor Microenvironment
16%
Breast Cancer
16%
Cancer Therapy
15%
CCL5
15%
Tumor Immunity
14%
Vps34
14%
Programmed Death-ligand 1 (PD-L1)
13%
SNAI1
12%
Autophagy Pathway
12%
Tumor Plasticity
12%
Autophagy-related Proteins
11%
Epithelial-to-mesenchymal Transition
11%
CXCR3
11%
Hypoxia-inducible factor-1α (HIF-1α)
10%
CXCL10
10%
Natural Killer
10%
Melanoma
10%
Cancer Metastasis
10%
Zinc Finger E-box Binding Homeobox 1 (ZEB1)
10%
Cell-mediated
9%
CMTM6
9%
Nanoluciferase
9%
Immune Checkpoint Inhibitors
9%
CD73
9%
Myeloma Cells
9%
CCR2
9%
Stimulator of Interferon Gene Protein
9%
Cluster of Differentiation 47 (CD47)
9%
Therapeutic Implications
8%
Immune Escape
8%
Immune Cells
8%
Hypoxic Stress
8%
ACKR2
8%
CMTM7
8%
Infiltration
7%
Anticancer Therapy
7%
Chemokine Receptor
7%
Anti-programmed Cell Death Protein 1 (anti-PD-1)
7%
Hypoxic Tumor
7%
Immune Cell Infiltration
7%
Melanocytic Tumor
7%
Therapeutic Target
6%
Major Challenges
6%
Improved Survival
6%
Tumoral
6%
Overexpression
6%
Cell Infiltration
6%
Cancer Treatment
6%
Immune Suppression
6%
Natural Killer Cell Activity
6%
Monocytic Myeloid-derived Suppressor Cells (M-MDSCs)
6%
Tumor-derived Microvesicles
6%
Glioblastoma
6%
Human Breast Cancer Cells
6%
Actin
6%
Gene Expression
5%
Treg
5%
Regulatory T Cells
5%
Drug-resistant Tumor
5%
Flow Cytometry Analysis
5%
MiR-210
5%
Cold Tumor
5%
Cytotoxicity
5%
Tumour-promoting Effect
5%
Receptor Systems
5%
Inducer
5%
Radiotherapy
5%
Cancer Patients
5%
Biochemistry, Genetics and Molecular Biology
Autophagy
100%
Natural Killer Cell
52%
Cancer Cell
51%
Cancer Immunotherapy
45%
CCL5
23%
PD-L1
22%
Immune Checkpoints
19%
Radiation Biology
19%
Immune Response
18%
Tumor Progression
18%
Immunocompetent Cell
17%
EMT
16%
Chemokine Receptor
14%
Genetics
14%
Chemokine
13%
T Cell
13%
Signal Transduction
12%
Radiosensitivity
12%
Tumor Immunity
11%
Gene Expression
11%
Cell Plasticity
11%
MicroRNA
11%
Mesenchymal-Epithelial Transition
11%
SNAI1
11%
CD8
11%
Cell Infiltration
10%
Vacuolar Protein Sorting
10%
Stimulator of Interferon Genes
10%
Anticancer
10%
Hypoxia Inducible Factor 1
10%
CXCL10
9%
Agonist
9%
CD47
9%
Cancer Stem Cell
9%
Immune Checkpoint Inhibitor
9%
Cell Migration
9%
Cytotoxic T Cell
9%
Carbon Cycle
8%
Promoter Region
8%
Biological Activity
8%
Cell Killing
7%
Serine
7%
Upregulation
7%
Molecular Mechanism
7%
Carcinogenesis
7%
Vascularization
7%
Magnetic Resonance Imaging
7%
Tumor Hypoxia
7%
Gene Signature
6%
Low Drug Dose
6%
Adenosine
6%
Stromal Cell
6%
Mouse Model
6%
Phosphoinositide 3-Kinase
6%
Actin
6%
Mitochondrion
6%
Kinase
5%
Phosphotransferase
5%
Drive
5%
Phagocytosis
5%
Isoform
5%
Adenosine Monophosphate
5%
Cyclic Guanosine Monophosphate
5%
Synthase
5%
BNIP3L
5%
Cell Function
5%
Cytokine
5%